CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale EVP, Global Head RA & Quality sold 25,750 shares at $0.62 ($15,888)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 24,844 shares at $0.72 ($17,888)
- 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 10,746 shares at $0.72 ($7,737)
- 4 Open-market sale EVP, Chief Legal Officer sold 10,044 shares at $0.72 ($7,232)
- 4 Open-market sale EVP, CFO sold 6,679 shares at an average $0.72 ($4,810)
- 4 Open-market sale EVP, Global Head RA & Quality sold 3,879 shares at $0.72 ($2,793)
- 4 Grant or award President and CEO acquired 1,280,000 shares (grant or award)
- 4 Grant or award EVP, Chief Sci. & Tech Officer acquired 675,000 shares (grant or award)
- 4 Grant or award EVP, Chief Legal Officer acquired 475,000 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 475,000 shares (grant or award)
- 4 Grant or award EVP, Global Head RA & Quality acquired 450,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 20,409 shares at $0.39 ($7,939)
- 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 8,856 shares at $0.39 ($3,445)
- 4 Open-market sale EVP, Chief Legal Officer sold 8,307 shares at $0.39 ($3,231)
- 4 Open-market sale EVP, Chief Medical Officer sold 12,287 shares at $0.39 ($4,780)
Page 4 of 33 · 644 filings